NorthWest Biotherapeutics Inc (NWBO)

[beachhyena]

Lets hope that this is not the goal but any sensible investor will always question Company Officers when there has been extensive dilution coupled by generous Option rewards to insiders.
The knack for keeping the price down to allow possible accumulation or possible covering as some suggest can be perceived negatively when spun for the purpose of scaring away retail investors or forcing retail to sell into this tactic.
Retail investors who lack the stomach or DD for these wildly swinging OTC stocks often get burned by their own ignorance or lack of DD or lack of patience.

Do any of us know if the Direct trial (Mayo Clinic) is set to kick off or are they waiting for funding from NWBO.
It seems that LP's suggestion that the L trial will continue for many months and a year to results may be perceived as a hidden tactic to get the Direct trial running which as Doc has suggested will deliver quick results of efficacy. Is the company making sure they have additional insurance in the Direct trial should the L trial fail to deliver or be rejected by the FDA.
Another question to NWBO is why would NWBO allow the NICE process to start if they had no intentions of sharing data this year, it just does not make sense. Maybe the scrubbing process is further along than most think but the ambiguity always relayed by the company in their press releases always seem to allow for confusion amongst retail who do not have an inside angle to the companies true timelines and strategic plan.
This company should be open to all types of financing to achieve it's goals over the coming years so to me the ambiguity and lack of concern regarding the SP point to a much bigger lucrative offer that is currently being tabled.
I expect to see some positive action regarding this proposed financing within the next month.
All IMHO of course.